These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 5527338)

  • 1. Growth hormone levels and chronic liver cirrhosis.
    Toccafondi R; Maioli M; Palmas S
    Riv Crit Clin Med; 1970; 70(1):120-5. PubMed ID: 5527338
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum glucose, insulin, and growth hormone in chronic hepatic cirrhosis.
    Samaan NA; Stone DB; Eckhardt RD
    Arch Intern Med; 1969 Aug; 124(2):149-52. PubMed ID: 5797073
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serum insulin and growth hormone during glucose loading in liver cirrhosis].
    Schatz H; Paumgartner G; Brunner H; Höfer R; Grabner G
    Wien Z Inn Med; 1971; 52(1):41-6. PubMed ID: 5540818
    [No Abstract]   [Full Text] [Related]  

  • 4. Cirrhosis and diabetes. V. Serum human growth hormone levels in Laennec's cirrhosis.
    Conn HO; Daughaday WH
    J Lab Clin Med; 1970 Oct; 76(4):678-88. PubMed ID: 5458029
    [No Abstract]   [Full Text] [Related]  

  • 5. Growth hormone in blood plasma of patients with liver cirrhosis.
    Kasperska-Czyzykowa T; Rogala H
    Acta Med Pol; 1978; 19(4):485-92. PubMed ID: 752250
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in hydrocarbon metabolism in hepatic cirrhosis. VI. HGH].
    Santolaria Fernández F; González García C; González Reimers E; Pérez Labajos P; Jorge Hernández J; Batista López N; Hernández Nieto L; Bueno Gómez J
    Rev Esp Enferm Apar Dig; 1983 Jun; 63(6):525-33. PubMed ID: 6878841
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in plasma nonesterified fatty acids and glycerol during an induced hyperglycemia test by intravenous route in alcoholic and hemochromatotic cirrhosis].
    Poupon R; Simon M; Lenoir P; Bourel M
    Sem Hop; 1972 Jun; 48(29):2105-12. PubMed ID: 4343039
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dynamics of concentration of insulin and growth hormone in blood serum in chronic liver diseases].
    Shlimovich PB; Sokolov IaA; Moskvichev AM
    Klin Med (Mosk); 1976 Jun; 54(6):90-5. PubMed ID: 972523
    [No Abstract]   [Full Text] [Related]  

  • 9. Growth hormone, insulinlike growth factor-1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease.
    Donaghy A; Ross R; Gimson A; Hughes SC; Holly J; Williams R
    Hepatology; 1995 Mar; 21(3):680-8. PubMed ID: 7533122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma insulin response to oral glucose in liver cirrhosis.
    Toccafondi R; Palmas S; Maioli M
    Riv Crit Clin Med; 1970; 70(1):110-9. PubMed ID: 5527337
    [No Abstract]   [Full Text] [Related]  

  • 11. Resistance to growth hormone in children with chronic liver disease.
    Bucuvalas JC; Horn JA; Chernausek SD
    Pediatr Transplant; 1997 Aug; 1(1):73-9. PubMed ID: 10084790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin and growth hormone responses to the serotonin antagonist, metergoline, in liver cirrhosis: further evidence for serotoninergic dysfunction.
    Borzio M; Caldara R; Ferrari C; Borzio F; Piepoli V; Romussi M
    Horm Metab Res; 1982 May; 14(5):277-8. PubMed ID: 7095740
    [No Abstract]   [Full Text] [Related]  

  • 13. Disturbances of metabolic homeostasis is liver disease.
    Alberti KG; Johnston DG; Piniewska-Hulas M; Whittaker J
    Acta Med Port; 1981; (Suppl 2):35-47. PubMed ID: 7015794
    [No Abstract]   [Full Text] [Related]  

  • 14. [The somatotropic hormone and liver diseases].
    Weber P; Martínek K; Cechácek Z
    Vnitr Lek; 1989 Jan; 35(1):36-42. PubMed ID: 2929149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prolactin and growth hormone in cirrhotic patients with and without physical signs of feminization].
    Martínez Verano JA; Alvarez Burgos ML; Borque Ibarra M; Casanueva F
    Rev Clin Esp; 1982 Apr; 165(1):23-6. PubMed ID: 6812174
    [No Abstract]   [Full Text] [Related]  

  • 16. Circulating growth hormone and insulin-like growth factor-I in nonalcoholic liver cirrhosis with or without superimposed hepatocarcinoma: evidence of an altered circadian rhythm.
    Buzzelli G; Dattolo P; Pinzani M; Brocchi A; Romano S; Gentilini P
    Am J Gastroenterol; 1993 Oct; 88(10):1744-8. PubMed ID: 8213718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The intravenous glucose tolerance test in patients with cholelithiasis and liver cirrhosis].
    Ratzmann KP; Meyer LW; Baufeld W
    Z Gesamte Inn Med; 1974 Apr; 29(8):331-3. PubMed ID: 4411172
    [No Abstract]   [Full Text] [Related]  

  • 18. Growth hormone/insulin-like growth factor 1 axis recovery after liver transplantation: a preliminary prospective study.
    Bassanello M; De Palo EF; Lancerin F; Vitale A; Gatti R; Montin U; Ciarleglio FA; Senzolo M; Burra P; Brolese A; Zanus G; D'Amico DF; Cillo U
    Liver Transpl; 2004 May; 10(5):692-8. PubMed ID: 15108263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Growth hormone and abnormal carbohydrate metabolism in patients with chronic renal failure].
    Martins Prata M; da Conceição Salgueiro M; Amparo Santos M
    Acta Med Port; 1984 Feb; 5(2):43-8. PubMed ID: 6720337
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum leptin levels in patients with nonalcoholic chronic liver disease.
    Nakamuta M; Tada S; Uchimura K; Enjoji M; Kinukawa N; Iwamoto H; Sugimoto R; Shimada M; Ohashi M; Sugimachi K; Nawata H
    Hepatogastroenterology; 2001; 48(38):527-32. PubMed ID: 11379347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.